About Us
Classes Of Business

HMO Reinsurance

Provider Excess Of Less

Medical Reinsurance

Employer Stop Loss

Client Captive Programs

Cell & Gene Therapy
Cost Containment
News
Contact Us

News
BioMarin finally secures FDA approval of hemophilia gene therapy

on June 29, 2023 (updated July 5, 2023) | Category: News

BioMarin finally secures FDA approval of hemophilia gene therapy

Click here to download PDF